Profile data is unavailable for this security.
About the company
JZJ Chain Drugstore Corp is a China-based company principally engaged in chain retail business. The Company operates primarily through three segments. The Pharmaceutical Retail and Services segment is mainly engaged in the retail of pharmaceuticals, health foods, personal care products, home health products and medical devices. The Convenience Sales segment is primarily engaged in the sales of convenience products such as convenience foods and daily consumables. The Company also operates Wholesale Sales segment. The Company is also engaged in the provision of professional services to pharmaceutical and convenience providers, as well as the provision of physical examination services to patients. The Company principally conducts its businesses in the domestic market.
- Revenue in CNY (TTM)9.10bn
- Net income in CNY127.90m
- Incorporated2004
- Employees17.63k
- LocationJZJ Chain Drugstore CorpComplex BuildingWanhong Jiayuan Fengyuan (Plot 5), LianmWanhong Road Intersection, Panlong DistrKUNMING 650224ChinaCHN
- Phone+86 87 165711920
- Fax+86 87 165711330
- Websitehttps://www.jzj.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical System Network Co Ltd | 5.78bn | 37.02m | 718.77m | 3.86k | 18.52 | 0.9041 | 3.73 | 0.1243 | 28.29 | 28.29 | 4,419.52 | 579.57 | 1.65 | 10.15 | 12.93 | 33,465,280.00 | 1.11 | 2.84 | 1.90 | 4.35 | 40.81 | 41.46 | 0.6735 | 1.68 | 0.6786 | 8.07 | 0.6557 | 18.79 | 6.09 | 3.06 | -32.15 | -- | 16.17 | 3.71 |
| Green Cross Health Ltd | 2.21bn | 73.14m | 826.34m | 248.00 | 11.42 | 1.20 | 4.76 | 0.3745 | 0.1217 | 0.1217 | 3.67 | 1.16 | 1.35 | 6.70 | 21.09 | -- | 5.55 | 5.53 | 7.53 | 7.95 | 57.46 | 59.21 | 4.12 | 4.18 | 0.5702 | 4.80 | 0.4313 | 41.79 | 3.94 | -1.63 | 32.76 | 3.44 | -4.28 | 8.45 |
| Dingdang Health Technology Group Ltd | 4.72bn | -342.97m | 1.03bn | 2.27k | -- | 0.6211 | -- | 0.2175 | -0.2942 | -0.2942 | 4.07 | 1.42 | 1.61 | 5.00 | 39.68 | 2,258,901.00 | -11.63 | -46.70 | -17.31 | -67.25 | 33.89 | 32.52 | -7.24 | -30.22 | 1.73 | -- | 0.1358 | -- | -3.87 | 29.63 | -66.73 | -- | -1.86 | -- |
| Kimia Farma Tbk PT | 3.74bn | -246.96m | 1.23bn | 9.64k | -- | 0.9172 | -- | 0.3279 | -143.10 | -143.10 | 1,977.01 | 583.30 | 0.5728 | 3.56 | 5.39 | 896,722,800.00 | -5.62 | -3.72 | -10.72 | -7.04 | 32.24 | 33.09 | -9.81 | -6.30 | 0.3837 | -0.9365 | 0.692 | -- | 0.6799 | 1.12 | 57.12 | -- | -25.74 | -- |
| Sipai Health Technology Co, Ltd | 3.42bn | -316.86m | 1.44bn | 2.95k | -- | 1.47 | -- | 0.422 | -0.57 | -0.57 | 6.20 | 1.50 | 1.44 | 14.81 | 7.29 | 1,191,090.00 | -15.51 | -52.80 | -28.98 | -79.72 | 9.74 | 8.16 | -10.75 | -34.60 | 1.67 | -- | 0.0252 | -- | -3.11 | 34.45 | -26.57 | -- | -8.64 | -- |
| JZJ Chain Drugstore Corp | 9.10bn | 127.90m | 3.21bn | 17.63k | 25.01 | 1.22 | -- | 0.3529 | 0.8305 | 0.8305 | 59.09 | 16.99 | 0.8898 | 2.10 | 15.58 | 516,114.80 | 1.27 | 4.24 | 2.67 | 8.13 | 35.31 | 35.31 | 1.43 | 4.12 | 0.3453 | 2.20 | 0.6304 | 48.72 | 2.23 | 21.34 | -69.08 | -5.29 | 15.00 | -- |
| Fangzhou Inc | 2.87bn | -23.63m | 3.25bn | 485.00 | -- | 20.97 | -- | 1.13 | -0.0199 | -0.0199 | 2.43 | 0.1263 | 4.29 | 13.75 | 74.78 | 6,658,309.00 | -3.53 | -- | -22.44 | -- | 18.02 | -- | -0.8227 | -- | 0.8734 | 0.1636 | 0.1956 | -- | 11.22 | -- | -334.42 | -- | -- | -- |
| Genky DrugStores Co Ltd | 9.46bn | 349.97m | 6.43bn | 1.84k | 18.06 | 2.45 | 9.89 | 0.6796 | 256.34 | 256.34 | 6,928.04 | 1,891.26 | 1.66 | 6.05 | 47.17 | 114,768,600.00 | 6.15 | 5.34 | 9.42 | 8.48 | 20.47 | 20.47 | 3.70 | 3.22 | 0.2809 | 48.77 | 0.3793 | 6.99 | 8.62 | 10.19 | 11.73 | 20.73 | 6.54 | 0.7875 |
| MedPlus Health Services Ltd | 4.99bn | 157.92m | 8.19bn | 25.00k | 51.87 | -- | 22.42 | 1.64 | 17.25 | 17.25 | 544.80 | -- | -- | -- | -- | 2,615,076.00 | -- | 3.44 | -- | 4.32 | 26.24 | 22.31 | 3.17 | 1.83 | -- | 2.67 | -- | 0.00 | 9.09 | 16.41 | 129.59 | 133.19 | 14.50 | -- |
Data as of Feb 11 2026. Currency figures normalised to JZJ Chain Drugstore Corp's reporting currency: Chinese Yuan Renminbi CNY
18.40%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2025 | 8.61m | 11.30% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 1.91m | 2.50% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2025 | 1.36m | 1.78% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 1.26m | 1.66% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2025 | 365.10k | 0.48% |
| BOCI-Prudential Asset Management Ltd.as of 30 Sep 2025 | 175.71k | 0.23% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2025 | 168.40k | 0.22% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 66.60k | 0.09% |
| Gfund Management Co., Ltd.as of 30 Jun 2025 | 61.70k | 0.08% |
| Peng Yang Amc Fund Management Co. Ltd.as of 30 Jun 2025 | 49.40k | 0.07% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
